Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer

• Main Authors: Mohsin Hamid (Author), Ali Ghani (Author), Ida Micaily (Author), Usman Sarwar (Author), Bilal Lashari (Author), Faizan Malik (Author)
• Format: Book
• Published: Greater Baltimore Medical Center, 2018-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Posterior reversible encephalopathy syndrome (PRES) is an increasingly recognizable neuro-clinical syndrome. Clinical and neurological manifestations of PRES include hypertension, headache, encephalopathy, seizures, and symmetrical white matter changes on brain MRI. Most common precipitants of PRES...